4basebio (LON:4BB) Stock Price Down 4.1% - Time to Sell?

Shares of 4basebio PLC (LON:4BB - Get Free Report) were down 4.1% on Friday . The stock traded as low as GBX 1,180 ($14.73) and last traded at GBX 1,180 ($14.73). Approximately 12 shares changed hands during mid-day trading, a decline of 98% from the average daily volume of 618 shares. The stock had previously closed at GBX 1,230 ($15.36).

4basebio Stock Down 4.1 %

The company has a quick ratio of 3.52, a current ratio of 2.73 and a debt-to-equity ratio of 201.47. The stock has a 50 day simple moving average of GBX 1,228.32 and a 200 day simple moving average of GBX 1,335.21. The stock has a market cap of £151.16 million, a price-to-earnings ratio of -1,512.82 and a beta of 1.09.

Insider Buying and Selling

In other news, insider Heikki Lanckriet bought 46,500 shares of the stock in a transaction on Friday, November 15th. The shares were purchased at an average cost of GBX 1,325 ($16.54) per share, for a total transaction of £616,125 ($769,290.80). 68.44% of the stock is owned by corporate insiders.

4basebio Company Profile

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients. Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.